Cocrystal Pharma, Inc. Common Stock —— 季度财务报表 (NASDAQ:COCP) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

Market Capitalization 12.96 M
Employee 10
Founded 2006
CEO N/A
Website www.cocrystalpharma.com
Headquarter Delaware, United States
FIGI BBG000V27360
Industry 生物技术

总收入

净利润

每股基本收益（基本 EPS）

总债务

自由现金流

现金及现金等价物

市盈率

-1.4

市销率

47.81

Related tickers

	#	姓名	价格	24小时 %	7天 %	一个月 %	一年 %	市值	最近7天
	4736	BLRX BioLineRx Ltd - American Depositary Shares	3.05 USD	-1.61%	+9.32%	-4.69%	+8.54%	13.27 M USD
	4739	INTS Intensity Therapeutics, Inc. - Common Stock	4.87 USD	-1.02%	+0.21%	+24.23%	+1375.76%	13.16 M USD
	4767	GDTC CytoMed Therapeutics Limited - Ordinary Shares	1.02 USD	+6.25%	+8.51%	-11.30%	-50.72%	12.07 M USD
	4769	MBRX Moleculin Biotech, Inc. - Common Stock	2.26 USD	+2.26%	0.00%	-18.71%	-28.25%	12.06 M USD